BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rafaniello C, Sessa M, Bernardi FF, Pozzi M, Cheli S, Cattaneo D, Baldelli S, Molteni M, Bernardini R, Rossi F, Clementi E, Bravaccio C, Radice S, Capuano A. The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. Pharmacogenomics J 2018;18:422-30. [PMID: 28719598 DOI: 10.1038/tpj.2017.38] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Hattori S, Suda A, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Taguri M, Hirayasu Y. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia. BMC Psychiatry 2018;18:231. [PMID: 30016952 DOI: 10.1186/s12888-018-1817-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Rossow KM, Oshikoya KA, Aka IT, Maxwell-Horn AC, Roden DM, Van Driest SL. Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics. J Dev Behav Pediatr 2021;42:205-12. [PMID: 33759847 DOI: 10.1097/DBP.0000000000000883] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Pozzi M, Pisano S, Marano G, Carnovale C, Bravaccio C, Rafaniello C, Capuano A, Rossi F, Rizzo R, Bernardini R, Nobile M, Molteni M, Clementi E, Biganzoli E, Radice S. Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting. J Child Adolesc Psychopharmacol 2019;29:133-40. [PMID: 30452281 DOI: 10.1089/cap.2018.0092] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
4 Saiz-Rodríguez M, Belmonte C, Román M, Ochoa D, Jiang-Zheng C, Koller D, Mejía G, Zubiaur P, Wojnicz A, Abad-Santos F. Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants. Basic Clin Pharmacol Toxicol 2018;123:474-85. [PMID: 29723928 DOI: 10.1111/bcpt.13031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
5 Belmonte C, Ochoa D, Román M, Saiz-rodríguez M, Wojnicz A, Gómez-sánchez CI, Martín-vílchez S, Abad-santos F. Influence of CYP2D6 , CYP3A4 , CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers. Basic Clin Pharmacol Toxicol 2018;122:596-605. [DOI: 10.1111/bcpt.12960] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
6 Sessa M, Mascolo A, Scavone C, Perone I, Di Giorgio A, Tari M, Fucile A, De Angelis A, Rasmussen DB, Jensen MT, Kragholm K, Rossi F, Capuano A, Sportiello L. Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study. Front Pharmacol 2018;9:1212. [PMID: 30459608 DOI: 10.3389/fphar.2018.01212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Maruf AA, Stein K, Arnold PD, Aitchison KJ, Müller DJ, Bousman C. CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review. J Child Adolesc Psychopharmacol 2021;31:33-45. [PMID: 33074724 DOI: 10.1089/cap.2020.0093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sessa M, di Mauro G, Mascolo A, Rafaniello C, Sportiello L, Scavone C, Capuano A. Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors. Front Pharmacol 2018;9:611. [PMID: 29946258 DOI: 10.3389/fphar.2018.00611] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
9 Vitorino C, Silva S, Bicker J, Falcão A, Fortuna A. Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges. Drug Discov Today 2019;24:1911-23. [PMID: 31181188 DOI: 10.1016/j.drudis.2019.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
10 Ivashchenko DV, Khoang SZ, Makhmudova BV, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Shuev GN, Dorina IV, Nastovich MI, Shagovenko EN, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA. Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation. Drug Metab Pers Ther 2020:/j/dmdi. [PMID: 32827391 DOI: 10.1515/dmpt-2020-0102] [Reference Citation Analysis]
11 Soria-Chacartegui P, Villapalos-García G, Zubiaur P, Abad-Santos F, Koller D. Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Front Pharmacol 2021;12:711940. [PMID: 34335273 DOI: 10.3389/fphar.2021.711940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fortinguerra S, Sorrenti V, Giusti P, Zusso M, Buriani A. Pharmacogenomic Characterization in Bipolar Spectrum Disorders. Pharmaceutics 2019;12:E13. [PMID: 31877761 DOI: 10.3390/pharmaceutics12010013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Rafaniello C, Sullo MG, Carnovale C, Pozzi M, Stelitano B, Radice S, Bernardini R, Rossi F, Clementi E, Capuano A. We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database. Front Psychiatry 2020;11:550201. [PMID: 33343407 DOI: 10.3389/fpsyt.2020.550201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Verma H, Silakari O. Investigating the Role of Missense SNPs on ALDH 1A1 mediated pharmacokinetic resistance to cyclophosphamide. Comput Biol Med 2020;125:103979. [PMID: 32877739 DOI: 10.1016/j.compbiomed.2020.103979] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Al-Eitan LN, Mohammad NN, Al-Maqableh HW, Hakooz NM, Dajani RB. Genetic Polymorphisms of Pharmacogenomic VIP Variants in the Circassian Subpopulation from Jordan. Curr Drug Metab 2019;20:674-81. [PMID: 31362667 DOI: 10.2174/1389200220666190729124000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Filipce A, Naumovska Z, Nestorovska AK, Sterjev Z, Brezovska K, Tonic-Ribarska J, Grozdanova A, Suturkova L, Raleva M. Evaluation of Correlation Between the Pharmacogenetic Profiles of Risperidone Treated Psychiatry Patients with Plasma and Urine Concentration of Risperidone and its Active Moiety 9-OH Risperidone Determined with Optimized Bioanalytical LC Method. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2018;39:97-106. [PMID: 30864366 DOI: 10.2478/prilozi-2018-0047] [Reference Citation Analysis]
17 Koller D, Belmonte C, Lubomirov R, Saiz-rodríguez M, Zubiaur P, Román M, Ochoa D, Carcas A, Wojnicz A, Abad-santos F. Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects. J Psychopharmacol 2018;32:1212-22. [DOI: 10.1177/0269881118798605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ruaño G, Tortora J, Robinson S, Baker S, Holford T, Winokur A, Goethe JW. Subanalysis of the CYP-GUIDES Trial: CYP2D6 Functional Stratification and Operational Timeline Selection. Psychiatry Res 2021;297:113571. [PMID: 33513485 DOI: 10.1016/j.psychres.2020.113571] [Reference Citation Analysis]
19 Scavone C, di Mauro G, Mascolo A, Berrino L, Rossi F, Capuano A. The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. Front Pharmacol 2019;10:111. [PMID: 30814951 DOI: 10.3389/fphar.2019.00111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
20 Mulder TAM, van Eerden RAG, de With M, Elens L, Hesselink DA, Matic M, Bins S, Mathijssen RHJ, van Schaik RHN. CYP3A422 Genotyping in Clinical Practice: Ready for Implementation? Front Genet 2021;12:711943. [PMID: 34306041 DOI: 10.3389/fgene.2021.711943] [Reference Citation Analysis]